Compounds > 2,4,5-trichlorophenoxyethanol
Page last updated: 2024-12-05

2,4,5-trichlorophenoxyethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4,5-trichlorophenoxyethanol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16462
SCHEMBL ID134595
MeSH IDM0067004

Synonyms (30)

Synonym
2-(2,4,5-trichlorophenoxy)ethanol
ethanol, 2-(2,4,5-trichlorophenoxy)-
nsc 59656
brn 2051565
klorinol
2,4,5-trichlorophenoxyethanol
einecs 218-333-7
ccris 5504
nsc 19197
fenteracol
nsc-59656
nsc59656
wln: q2or bg dg eg
2122-77-2
nsc19197
2-(2,5-trichlorophenoxy)ethanol
ethanol,4,5-trichlorophenoxy)-
nsc-19197
tcpe
4-06-00-00964 (beilstein handbook reference)
fenteracol [iso]
ek76w4j89b ,
unii-ek76w4j89b
AKOS008979114
ethanol,2-(2,4,5-trichlorophenoxy)-
SCHEMBL134595
2-(2,4,5-trichloro-phenoxy)-ethanol
ATKFMEGWDYLXBP-UHFFFAOYSA-N
DTXSID70175451
Q27889448
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
2,4,5-trichlorophenoxyacetic acid
2,4,5-Trichlorophenoxyacetic Acid: An herbicide with strong irritant properties. Use of this compound on rice fields, orchards, sugarcane, rangeland, and other noncrop sites was terminated by the EPA in 1985. (From Merck Index, 11th ed). (2,4,5-trichlorophenoxy)acetic acid : A chlorophenoxyacetic acid that is phenoxyacetic acid in which the ring hydrogens at postions 2, 4 and 5 are substituted by chlorines.		3.9740chlorophenoxyacetic acid;
trichlorobenzene		defoliant;
phenoxy herbicide;
synthetic auxin
2,3,4,6-tetrachlorophenol
2,3,4,6-tetrachlorophenol: RN given refers to parent cpd; see also record for tetrachlorophenol with locants for chloro groups not specified. 2,3,4,6-tetrachlorophenol : A tetrachlorophenol in which the chlorines are located at positions 2, 3, 4, and 6.		1.9510tetrachlorophenolxenobiotic metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Experimental Hepatoma
[description not available]		01.9510
Experimental Neoplasms
[description not available]		01.9510
Dermatoses
[description not available]		01.9510
Amyloidosis
A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.		01.9510
Skin Diseases
Diseases involving the DERMIS or EPIDERMIS.		01.9510
Cancer of Liver
[description not available]		03.2820
Liver Neoplasms
Tumors or cancer of the LIVER.		03.2820